miR‑433 protects pancreatic β cell growth in high‑glucose conditions

Area of Science:

• Endocrinology
• Molecular Biology
• Cell Biology

Background:

• Pancreatic beta cell dysfunction is central to diabetes mellitus (DM) pathogenesis.
• MicroRNAs (miRNAs) are implicated in DM, but their specific roles in regulating beta cell function under high glucose remain unclear.

Purpose of the Study:

• To investigate the effect of miR-433 on pancreatic beta cell growth under high glucose conditions.
• To elucidate the underlying mechanisms by which miR-433 influences beta cell function.

Main Methods:

• Quantitative polymerase chain reaction (RT-qPCR) to measure miRNA expression in Min-6 cells.
• In vitro assays (Cell Counting Kit-8, colony formation, flow cytometry) to assess cell viability, proliferation, and apoptosis.
• Bioinformatics and luciferase assays to identify miR-433 targets, specifically cyclooxygenase 2 (COX2).

Main Results:

• miR-433 expression was significantly downregulated in Min-6 cells cultured in high glucose medium.
• Overexpression of miR-433 enhanced beta cell viability and proliferation by promoting cell cycle progression and reducing apoptosis.
• miR-433 directly targets and inhibits cyclooxygenase 2 (COX2) expression.
• Knockdown of COX2 mimicked the protective effects of miR-433 overexpression against high glucose-induced growth inhibition.

Conclusions:

• miR-433 plays a protective role in pancreatic beta cells exposed to high glucose.
• The mechanism involves the inhibition of COX2 expression.
• miR-433 demonstrates potential as a therapeutic agent for preventing and treating diabetes mellitus.